🇺🇸 FDA
Pipeline program

Direct-Acting Oral Anticoagulants (used as per local standard practice)

RG442-21

Phase 3 small_molecule active

Quick answer

Direct-Acting Oral Anticoagulants (used as per local standard practice) for Traumatic Intracranial Haemorrhage is a Phase 3 program (small_molecule) at UNITED THERAPEUTICS Corp with 1 ClinicalTrials.gov record(s).

Program details

Company
UNITED THERAPEUTICS Corp
Indication
Traumatic Intracranial Haemorrhage
Phase
Phase 3
Modality
small_molecule
Status
active

Clinical trials